Bdx0l 0001 01
3% Sodium Chloride Injection, Solution
Product Images NDC 17271-703
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for 3% Sodium Chloride (NDC 17271-703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Becton Dickinson And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bdx0l 0001 02
Bdx0l 0001 03
This is a description of a medication called "freeflex®," specifically a 3% sodium chloride injection. It is used intravenously and is only available by prescription. It contains 15 grams of sodium chloride per 500 mL or 30 mg per mL. The medication is hypertonic and may cause vein damage. It comes in a single-dose container and should be discarded if unused. The container closure is not made with natural rubber latex and is non-PVC and non-DEHP. The usual dosage is not provided in the text, and it should be stored at 20° to 25°C until ready to use. The manufacturer is Fresenius Kabi, and it is distributed by BD.*
Bdx0l 0001 04
This is a description of 3% Sodium Chloride Injection produced by BD and distributed by Fresenius Kabi. The solution is hypertonic saline for intravenous use, and each container holds 15 grams per 500 mL of solution. The product comes in a package with 20 single-dose containers and is only available with a prescription. The product should be stored at room temperature and protected from excessive heat. The product information includes the NDC number, dosage, manufacturer's details, lot number, and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
